MK-677 activates neurons in the hypothalamic arcuate nucleus in living animals, confirming the brain as a primary site of action for this oral GH secretagogue.
Arcuate nucleus activation confirmedMK-677 induced c-Fos in hypothalamic neurons, proving central mechanism of GH-releasing action
What the researchers found
MK-0677 induced c-Fos expression in arcuate nucleus neurons in vivo, confirming direct hypothalamic activation as a mechanism for its GH-releasing effect.
Why it matters
Confirming that MK-677 works through the hypothalamus (not just the pituitary) means it activates the body's natural GH-releasing pathway, which helps explain why it produces physiological pulsatile GH release rather than unnatural continuous elevation.
How the study worked
In vivo rat study using systemic MK-0677 administration, immunohistochemistry for c-Fos (neuronal activation marker), and anatomical mapping of activated neurons in the hypothalamus.
What this study cannot tell us
Rat model — human hypothalamic anatomy differs somewhat. c-Fos is an indirect marker of activation. Single time point analysis doesn't capture dynamic neuronal responses.
How to read the evidence
Well-designed in vivo neuroanatomy study with appropriate controls. Confirms a specific mechanism but limited to animal data.
When this study was published
Published in 1998 during peak MK-677 research activity. This mechanistic finding remains foundational to understanding how MK-677 stimulates GH release.
The bigger picture
MK-677 was one of the most promising oral GH secretagogues in development. Understanding that it works centrally through the arcuate nucleus — the brain's GH control center — validates that it integrates into the normal neuroendocrine axis rather than bypassing it, which has implications for its safety profile and physiological appropriateness.
Questions still open
- Does chronic MK-677 use alter arcuate nucleus neuron sensitivity over time?
- Are the activated neurons GHRH-producing or NPY/AgRP neurons?
- Does this central activation mechanism explain MK-677's effects on appetite and sleep?
Common questions
What is the arcuate nucleus and why does it matter?
How does MK-677 differ from injectable GH-releasing peptides?
Read the original research
The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo.
Journal of neuroendocrinology, 10(2), 111-8
Citation
Bailey, A R; Smith, R G; Leng, G. (1998). The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo.. Journal of neuroendocrinology, 10(2), 111-8.